InvestorsHub Logo
Followers 1
Posts 59
Boards Moderated 0
Alias Born 01/17/2017

Re: fink post# 909

Monday, 11/16/2020 8:13:22 PM

Monday, November 16, 2020 8:13:22 PM

Post# of 977
A Gilead buy out would be a real long shot considering they bought out a company with a similar therapeutic earlier this year.

https://www.gilead.com/news-and-press/press-room/press-releases/2020/3/gilead-to-acquire-forty-seven-for-49-billion

P.S. Why would $2.5bn be an appropriate value for TRIL when GILD paid $4.9bn for 47?